Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2-ALK fusion

Am J Hematol. 2023 Feb;98(2):365-367. doi: 10.1002/ajh.26107. Epub 2021 Feb 12.

Authors

Christopher B Hergott¹, Paola Dal Cin¹, Jason L Hornick¹, Eric S Winer², Ruben D Carrasco^{1

3}, Annette S Kim¹

Affiliations

¹ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
³ Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

PMID: 33491794
DOI: 10.1002/ajh.26107

No abstract available

MeSH terms

Humans
Leukemia, Myelomonocytic, Chronic* / genetics
Nuclear Envelope* / metabolism
Nuclear Pore Complex Proteins / genetics
Oncogene Proteins, Fusion / genetics
Oncogene Proteins, Fusion / metabolism
Receptor Protein-Tyrosine Kinases / metabolism

Substances

ran-binding protein 2
Nuclear Pore Complex Proteins
Receptor Protein-Tyrosine Kinases
Oncogene Proteins, Fusion